Identification of immune‐enhanced molecular subtype associated with BRCA1 mutations, immune checkpoints and clinical outcome in ovarian carcinoma

Ovarian carcinoma has the highest mortality among the malignant tumours in gynaecology, and new treatment strategies are urgently needed to improve the clinical status of ovarian carcinoma patients. The Cancer Genome Atlas (TCGA) cohort were performed to explore the immune function of the internal e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Cell Mol Med
Päätekijät: Zheng, Mingjun, Hu, Yuexin, Gou, Rui, Liu, Ouxuan, Nie, Xin, Li, Xiao, Liu, Qing, Hao, Yingying, Liu, Juanjuan, Lin, Bei
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2020
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7077593/
https://ncbi.nlm.nih.gov/pubmed/31995855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14830
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia